论文信息 - Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team. - 字舞流文

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.

S. Lee | P. Krogstad | S. Nachman | J. Jackson | E. Abrams | A. Kovacs | J. Mcnamara | A. Wiznia | J. Moye | M. Bamji | M. Bamji | A. Dieudonne | K. Stanley | G. Johnson | H. Mendez | R. Aguayo | S. Rana | J. Sever | Sohail Rana | Hermann Mendez | Sophia S. Lee | Rosaura Aguayo | Elaine Abrams | John Sever | Elaine J. Abrams